Cite
MLA Citation
Jennifer Weiss et al.. “Sacituzumab govitecan: breakthrough targeted therapy for triple-negative breast cancer.” Expert review of anticancer therapy, vol. 19, no. 8, 2019, pp. 673–679. http://access.bl.uk/ark:/81055/vdc_100089563593.0x000029